Asahiro Morishita

HMGA2 Is a Driver of Tumor Metastasis

Asahiro Morishita, M. Raza Zaidi, Akira Mitoro et al. · Cancer Research · 2013 · 267 citations · Full text

Medicine, Cell Biology, Oncology +17

Liver cancer in 2021: Global Burden of Disease study

En Ying Tan, Pojsakorn Danpanichkul, Jie Ning Yong et al. · Journal of Hepatology · 2024 · 180 citations

Medicine, Health Sciences, Oncology +16

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis

Margherita Rimini, Lorenza Rimassa, Kazuomi Ueshima et al. · ESMO Open · 2022 · 130 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +14

Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population

Andrea Casadei‐Gardini, Margherita Rimini, Toshifumi Tada et al. · European Journal of Cancer · 2022 · 129 citations · Full text

Medicine, Oncology, Pharmacology +15

Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study

Hideki Fujii, Michihiro Iwaki, Hideki Hayashi et al. · Clinical Gastroenterology and Hepatology · 2022 · 106 citations

Medicine, Internal Medicine, Pathology +13